So, You Want to Become a CDMO…
August 24, 2021
Looking to pivot your business model to a CDMO service offering? Here’s what to keep in mind.
1 min read
August 2021
We take a deep dive into the cell therapy sector in our cover feature and ask what progress is being made in the fight against solid tumors. Meanwhile in NextGen, researchers from Carnegie Mellon University explain how AI can be used to source new pharmaceutical compounds derived from natural sources. Pierre Bourdage, Global Head of Biopharmaceuticals at Sandoz, also gives his take on the future of biosimilars, in Business. We also sit down with Andrew Moore, who tells us how he has used his military experience to inform his approach to leadership in the pharmaceutical industry.
Leadership Star
August 13, 2021
Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne, Pittsburgh, Pennsylvania, USA
1 min read
What Lies Ahead for Biosimilars?
August 12, 2021
The advent of biosimilars promises to make the world a healthier place by bringing more affordable biologic medicines to patients in need
1 min read
Sustainability in Bacterial Endotoxin Testing (BET) – A Holistic Approach to Conservation and Recombinant Technology
August 11, 2021
How a holistic approach to horseshoe crab sustainability – involving non-animal alternatives to LAL, transparency, careful monitoring, and IVF programs – will allow the industry to maintain stocks while protecting patients
1 min read
AI Reunites Pharma with Mother Nature
August 10, 2021
Can AI facilitate a grand comeback for medicines sourced from Mother Nature?
1 min read
Getting it Right from the Start: Simulation Optimizes Supply Chain Planning for Clinical Trials
August 10, 2021
Clinical supply chains are inherently dynamic and ambiguous, contributing to a high degree of uncertainty when trying to match drug supply to research needs at every stage of clinical development. By modelling this uncertainty, simulation tools can provide robust forecasts to help ensure investigational therapies get to patients when they are needed, and to reduce waste and development costs.
1 min read
A Matter of Expression
August 9, 2021
Lonza and Cytena combine expertise to allow biotherapeutic manufacturers to benefit from the advantages of Pichia pastoris as an expression system
1 min read
Marrying Up Proteins using Molecular Glues
August 4, 2021
New research uses mass spec to identify new drugs that “glue” proteins together
1 min read
High Fines for High Prices
August 3, 2021
UK company fined for massively hiking the price of a generic drug
1 min read
Nano-Origami Versus Infectious Agents
July 31, 2021
A team of researchers in Munich have found a way to trap viruses inside man-made nanomaterials
1 min read
Keeping Pace with the Plague
July 28, 2021
Global regulators attend a virtual workshop on second-generation COVID-19 vaccines
1 min read
Hope in the Fight Against Malaria
July 22, 2021
Trials of new malaria vaccine find high levels of durable protection
1 min read
Think of the Patients
July 20, 2021
GlaxoSmithKline’s Senior Vice President of US Oncology speaks with us about the pandemic and its impact on patients
1 min read
Continuous Progress
July 19, 2021
There are still barriers to the uptake of continuous manufacturing – but clear regulatory guidance can help companies overcome them
1 min read
COVID-19 and Beyond: Focusing on Patient-Centricity
July 17, 2021
Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA) discusses how the organization, along with its members , is working on adopting a more patient centric approach to manufacturing
1 min read
The Value of a Pack
June 25, 2021
As trials change and adapt, so too must clinical packaging. Companies must consider their design early on.
1 min read
Eliminating Bioconjugation Roadblocks
May 29, 2021
Bioconjugation of macromolecules to solid phase surfaces hasn’t always been the most straightforward of processes. But to take vaccine and drug development to a new level, we need to find a better approach.
1 min read
